208 results on '"Reid, John L."'
Search Results
2. A Computer-Based Shared-Care Scheme for Hypertension in Glasgow: Feasibility and Acceptability
3. Responsiveness to Calcium Antagonists in Essential Hypertension: Pharmacokinetic and Neurohumoral Aspects
4. CENTRAL CATECHOLAMINES AND RENOVASCULAR HYPERTENSION IN THE RAT
5. CARDIOVASCULAR REACTIONS TO BROMOCRIPTINE
6. Foreword
7. Central and Peripheral Alpha-Adrenoreceptors and the Actions of Clonidine and Methyldopa
8. Clonidine and Imidazolines as Antihypertensive Agents
9. LIST OF PARTICIPANTS
10. Hidden Costs of Passive Restoration
11. Setting-up a Blood Pressure and Vascular Protection Clinic: Requirements of the European Society of Hypertension
12. Risks of socioeconomic deprivation on mortality in hypertensive patients
13. Fall and Rise of Polypharmacy?
14. Reducing Stroke Risk in Hypertensive Patients: Asian Consensus Conference Recommendations
15. Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial
16. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial
17. Medicine‐taking behavior: Implications of suboptimal compliance in Parkinson's disease
18. Review: Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?
19. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke
20. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study
21. Increased Levels of Superoxide in Brains from Old Female Rats
22. Efficacy and Tolerability of Long-Term Rilmenidine Treatment in Hypertensive Diabetic Patients
23. Clinical Pharmacology and the Management of Cardiovascular Diseases
24. Effect of Area-Based Deprivation on the Severity, Subtype, and Outcome of Ischemic Stroke
25. Cardiovascular outcomes after first-ever treatment of hypertension with angiotensin converting enzyme inhibitors or calcium channel-blockers in primary care
26. Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis
27. Nebivolol: The Role of Nitric Oxide in Hypertension Concluding Remarks
28. Radial artery hypertrophy occurs in coronary atherosclerosis and is independent of blood pressure
29. Radial artery hypertrophy occurs in coronary atherosclerosis and is independent of blood pressure
30. Bradykinin B 2 Receptor Antagonism Attenuates Blood Pressure Response to Acute Angiotensin-Converting Enzyme Inhibition in Normal Men
31. DNA Synthesis and Apoptosis in Smooth Muscle Cells From a Model of Genetic Hypertension
32. Superoxide Anion Production Is Increased in a Model of Genetic Hypertension
33. Telemetry for Cardiovascular Monitoring in a Pharmacological Study
34. Drug Treatment—Antihypertensive Drugs—The Present Role of Beta Blockers and Alpha Blockers
35. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
36. Determinants of the blood pressure response to the first dose of ACE inhibitor in mild to moderate congestive heart failure
37. Susceptibility to Cerebral Infarction in the Stroke-Prone Spontaneously Hypertensive Rat Is Inherited as a Dominant Trait
38. Endothelium Dependent and Independent Relaxation of Aortic Rings from Watanabe Heritable Hyperlipidemic Rabbits after Exposure to a Free Radical Generating System
39. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo
40. Sex Differences in the Abundance of Endothelial Nitric Oxide in a Model of Genetic Hypertension
41. Adverse event with first-dose perindopril in congestive heart failure
42. Effects of nitric oxide and superoxide on relaxation in human artery and vein
43. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus
44. Clinical Pharmacology and Therapeutics-past, present and future
45. Introduction
46. The role of angiotensin II and nitric oxide in genetic hypertension: comparison with L-NAME hypertension
47. White-coat hypertension as a cause of cardiovascular dysfunction
48. New therapeutic agents for hypertension
49. Vascular Smooth Muscle Polyploidy and Cardiac Hypertrophy in Genetic Hypertension
50. Effects of Manipulation of Dietary Cholesterol on the Function of the Thoracic Aorta from New Zealand White Rabbits
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.